Companies: 10,795·Total market cap: $144.5T
Emergent BioSolutions Inc.

Emergent BioSolutions Inc.

EBSNYSEHealthcare● Active
$8.00
$-0.07(-0.87%)
Market Cap$412770400
P/E Ratio—
52W High$14.06
52W Low$5.62
Overview
Stock ranking:Biotechnology·Healthcare·View All Market Cap Rankings →

Emergent BioSolutions Inc. (EBS) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · EBS · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-0.17ebs eps ttm · ebs earnings per shareEarnings history
PE Ratio (TTM)—ebs pe ratio ttm · ebs price to earningsPE Ratio deep dive
Revenue (TTM)$676.8Mebs revenue ttm · ebs annual revenueFull revenue history
Dividend YieldNo Dividenddoes ebs pay dividends · ebs dividend yieldDividend history
Shares Outstanding53.5Mebs shares outstanding · ebs floatShares outstanding history
Next EarningsAug 5, 2026Est.ebs earnings date · ebs next earningsEarnings history

Explore Emergent BioSolutions Inc. Data

ebs stock data · financials
Market Cap$412.8Mebs market cap · ebs valuation
Analyst Forecast$12 · Buy
DividendsNo Dividenddoes emergent biosolutions inc. pay dividends · ebs dividend yield
Revenue$742.9M-28.81%emergent biosolutions inc. annual revenue · ebs revenue
EarningsEPS $0.98+127.22%ebs earnings · ebs eps
PE Ratio—ebs pe ratio · ebs price to earnings

Financial Snapshot

Full Financials
FY 2025Revenue$742.9M▼ 28.81% YoY
202320242025
emergent biosolutions inc. revenue · ebs revenue 2025
FY 2025Net Income$52.6M▲ +127.60% YoY
202320242025
emergent biosolutions inc. net income · ebs profit 2025
FY 2025EPS$0.98▲ +127.22% YoY
202320242025
ebs eps · emergent biosolutions inc. earnings per share 2025
TTM:Revenue: $676.8MNet Income: -$8.6MEPS: $-0.17View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy15 analystsis ebs a buy · ebs analyst rating
Strong Buy
0
Buy
11
Hold
3
Sell
1
Strong Sell
0
12-Month Price Target
$12.00Low
$8.00Current
$12.00Avg Target50.00% upside
$12.00High
ebs price target · ebs 12 month forecast

Total: 15 · Buy rate: 73.3%

The EBS analyst consensus is Buy, based on ratings from 15 Wall Street analysts over the past 3 months. The average 12-month price target is $12.00, representing +50.00% upside from the current price of $8.00.

Stock Performance

Full History
1D+1.12%
1W-0.49%
1M-14.11%
3M-1.57%
YTD-33.98%
1Y+25.73%
5Y-87.23%

About Emergent BioSolutions Inc.

CEOJoseph C. Papa Jr.
IPO DateNov 15, 2006
Employees900
CountryUS
Websiteemergentbiosolutions.com

Emergent BioSolutions Inc. is a life sciences company dedicated to providing vital preparedness and response solutions for a wide range of public health threats (PHTs) across the United States. These …

BiotechnologyHealthcareNYSEUS

what is emergent biosolutions inc. · ebs stock overview · emergent biosolutions inc. company profile · who is emergent biosolutions inc. ceo · ebs NYSE · emergent biosolutions inc. headquarters · emergent biosolutions inc. business segments

About Stock Overview & Key Data

Emergent BioSolutions Inc. (EBS) is a Healthcare company in the Biotechnology industry, listed on NYSE since Nov 15, 2006. As of the latest trading session, EBS stock price is $8.00, with a market capitalization of $412.8M. The stock has returned +25.73% over the past 12 months and -33.98% year-to-date.

According to 15 Wall Street analysts, the consensus rating for Emergent BioSolutions Inc. stock is Buy, with an average 12-month price target of $12.00. In fiscal year 2025, Emergent BioSolutions Inc. reported revenue of $742.9M and net income of $52.6M. For detailed data — including Emergent BioSolutions Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Emergent BioSolutions Inc. (EBS) stock price is $8.00. The stock is traded on NYSE under the ticker symbol EBS. The 52-week range is $5.62 – $14.06.

EBS stock priceEBS quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice